Pancreatic cancer study finds most early staging is inaccurate

Staging of patients with early pancreatic cancer is inaccurate as much as 80% of the time, according to a new Cedars-Sinai Cancer study published in JAMA. The finding underscores the urgent need for advancements in diagnostic technology and staging, which could significantly alter early pancreatic cancer treatment and research.

This article was originally published on MedicalXpress.com

You may also be interested in:

Read More:

Lawyers Lookup